Pharmaceutical

Prokarium bolsters IP portfolio with two new US patents

UK-based biopharmaceutical company Prokarium has received two Notices of Allowance from the US Patent and Trademark Office.

Nov 5, 2024 - 06:00
Prokarium bolsters IP portfolio with two new US patents
UK-based biopharmaceutical company Prokarium has received two Notices of Allowance from the US Patent and Trademark Office.
Read the original article

Tags:

Previous Article

US Election: In close race, tiny Senate majority, not President, will hold power

Next Article

FDA grants fast track status to FELIQS’s FLQ-101 to prevent ROP

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

CT-080 by First Condor Group for Esophageal Cancer: Lik...

Oct 3, 2023

Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions

Signal: Porosome files comprehensive patent for therapi...

Aug 22, 2023

Genprex’s Reqorsa gene therapy picks up orphan drug designation from FDA for SCLC

Genprex’s Reqorsa gene therapy picks up orphan drug des...

Aug 12, 2023